Galapagos NV (GLPG)Healthcare | Biotechnology | Mechelen, Belgium | NasdaqGS
29.28 USD
+0.42
(1.455%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 29.28 Short-term: ★★☆☆☆ | Long-term: ★★★☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 1:23 p.m. EDT
Galapagos NV shows a slight downside lean in the short term due to mixed options positioning and recent price weakness, but its long-term fundamentals remain neutral with potential for growth. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.075108 |
| AutoTheta | 0.077476 |
| AutoETS | 0.077505 |
| AutoARIMA | 0.077505 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 40% |
| H-stat | 86.03 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.057 |
| Excess Kurtosis | -1.33 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.214 |
| Revenue per Share | 0.84395 |
| Market Cap | 1,966,424,192 |
| Trailing P/E | 5.11 |
| Forward P/E | -18.22 |
| Beta | 0.15 |
| Profit Margins | 28.85% |
| Website | https://www.glpg.com |
As of April 18, 2026, 1:23 p.m. EDT: Options speculators are showing mixed signals. Puts are heavily positioned around the 27.5 strike, indicating potential bearish sentiment, while calls are showing interest in the 30.0 and 35.0 strikes, suggesting some bullish bias. However, the overall options flow does not strongly indicate a clear directional move in the short term.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.1883117 |
| Address1 | Generaal De Wittelaan L11 A3 |
| All Time High | 274.03 |
| All Time Low | 12.91 |
| Ask | 29.38 |
| Ask Size | 1 |
| Average Analyst Rating | 3.0 - Hold |
| Average Daily Volume10 Day | 134,020 |
| Average Daily Volume3 Month | 142,893 |
| Average Volume | 142,893 |
| Average Volume10Days | 134,020 |
| Beta | 0.154 |
| Bid | 29.21 |
| Bid Size | 1 |
| Book Value | 2.8987663 |
| City | Mechelen |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Belgium |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 29.28 |
| Current Ratio | 20.145 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 29.44 |
| Day Low | 29.07 |
| Debt To Equity | 0.214 |
| Display Name | Galapagos |
| Earnings Call Timestamp End | 1,771,938,000 |
| Earnings Call Timestamp Start | 1,771,938,000 |
| Earnings Growth | 30.36 |
| Earnings Quarterly Growth | 29.906 |
| Earnings Timestamp | 1,778,097,600 |
| Earnings Timestamp End | 1,778,097,600 |
| Earnings Timestamp Start | 1,778,097,600 |
| Ebitda | 568,172,032 |
| Ebitda Margins | 0.51083 |
| Enterprise To Ebitda | -1.869 |
| Enterprise To Revenue | -0.955 |
| Enterprise Value | -1,061,666,752 |
| Eps Current Year | -6.22333 |
| Eps Forward | -1.6067415 |
| Eps Trailing Twelve Months | 5.73 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 32 1 534 29 01 |
| Fifty Day Average | 31.8406 |
| Fifty Day Average Change | -2.5605984 |
| Fifty Day Average Change Percent | -0.08041929 |
| Fifty Two Week Change Percent | 18.83117 |
| Fifty Two Week High | 37.78 |
| Fifty Two Week High Change | -8.499998 |
| Fifty Two Week High Change Percent | -0.22498672 |
| Fifty Two Week Low | 24.31 |
| Fifty Two Week Low Change | 4.970001 |
| Fifty Two Week Low Change Percent | 0.20444266 |
| Fifty Two Week Range | 24.31 - 37.78 |
| Financial Currency | EUR |
| First Trade Date Milliseconds | 1,330,353,000,000 |
| Float Shares | 44,538,512 |
| Forward Eps | -1.6067415 |
| Forward P E | -18.223217 |
| Free Cashflow | 344,640,512 |
| Full Exchange Name | NasdaqGS |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.56021 |
| Gross Profits | 623,091,008 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.25354 |
| Held Percent Institutions | 0.22611 |
| Implied Shares Outstanding | 67,159,294 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that is in phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium. |
| Long Name | Galapagos NV |
| Market | us_market |
| Market Cap | 1,966,424,192 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1716658 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | 319,492,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,917,381,696 |
| Number Of Analyst Opinions | 1 |
| Open | 29.25 |
| Operating Cashflow | -257,456,000 |
| Operating Margins | 0.87996 |
| Payout Ratio | 0.0 |
| Phone | 32 1 534 29 00 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 29.28 |
| Post Market Time | 1,776,456,605 |
| Previous Close | 28.86 |
| Price Eps Current Year | -4.704877 |
| Price Hint | 2 |
| Price To Book | 10.100849 |
| Price To Sales Trailing12 Months | 1.7679727 |
| Profit Margins | 0.2885 |
| Quick Ratio | 19.961 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 3.0 |
| Region | US |
| Regular Market Change | 0.42 |
| Regular Market Change Percent | 1.4553 |
| Regular Market Day High | 29.44 |
| Regular Market Day Low | 29.07 |
| Regular Market Day Range | 29.07 - 29.44 |
| Regular Market Open | 29.25 |
| Regular Market Previous Close | 28.86 |
| Regular Market Price | 29.28 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 90,743 |
| Return On Assets | 0.08871 |
| Return On Equity | 0.10419 |
| Revenue Growth | 10.932 |
| Revenue Per Share | 0.84395 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 65,897,071 |
| Shares Percent Shares Out | 0.0166 |
| Shares Short | 1,096,114 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 794,191 |
| Short Name | Galapagos NV |
| Short Percent Of Float | 0.0271 |
| Short Ratio | 5.89 |
| Source Interval | 15 |
| Symbol | GLPG |
| Target High Price | 28.550245 |
| Target Low Price | 28.550245 |
| Target Mean Price | 28.550245 |
| Target Median Price | 28.550245 |
| Total Cash | 2,998,048,000 |
| Total Cash Per Share | 45.496 |
| Total Debt | 6,915,000 |
| Total Revenue | 1,112,248,064 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 5.73 |
| Trailing P E | 5.1099477 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 32.26865 |
| Two Hundred Day Average Change | -2.9886494 |
| Two Hundred Day Average Change Percent | -0.092617735 |
| Type Disp | Equity |
| Volume | 90,743 |
| Website | https://www.glpg.com |
| Zip | 2,800 |